Stock Fundamentals

Company Information

Company Name
Regenxbio Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US75901B1070
CIK: 0001590877
CUSIP: 75901B107
Currency: USD
Full Time Employees: 371
Phone: 240 552 8181
Fiscal Year End: December
IPO Date: Sep 17, 2015
Description:

REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's products in pipeline includes ABBV-RGX-314 for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other chronic retinal diseases; and RGX-202 for the treatment of Duchenne muscular dystrophy, as well as RGX-121 for the treatment of mucopolysaccharidosis type II. It also develops RGX-111 for the treatment of mucopolysaccharidosis type I. In addition, the company licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies. Further, it has a collaboration and license agreement with AbbVie Global Enterprises Ltd. to develop ABBV-RGX-314 and with Nippon Shinyaku Co., Ltd. to develop RGX-121 and RGX-111 outside the United States. REGENXBIO Inc. was incorporated in 2008 and is headquartered in Rockville, Maryland.

Address:

9804 Medical Center Drive, Rockville, MD, United States, 20850

Directors & Officers

Name Title Year Born
Mr. Curran M. Simpson M.S. President, CEO & Director 1962
Mr. Patrick J. Christmas II, J.D. Executive VP & Chief Strategy and Legal Officer 1971
Dr. Stephen Pakola M.D. Executive VP & Chief Medical Officer 1969
Mr. Mitchell Chan M.B.A. Executive VP & CFO 1981
Mr. Craig Malzahn Executive VP of Product Development & CTO 1973
Dr. Olivier Danos Ph.D. Executive VP & Chief Scientific Officer 1958
Ms. Shiva G. Fritsch Chief Communications & People Officer NA
Dr. Ram Palanki Pharm.D. Executive VP & Chief Commercial Officer 1976
Ms. Nina Hunter SVP of Global Regulatory Strategy and Quality NA
Dr. Jahannaz Dastgir D.O. Clinical Development Lead NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 10, 2026 Steve Pakola N/A Sale 5.12K $10.35 $53.03K
Oct 09, 2025 Curran Simpson N/A Sale 20.81K $12.62 $262.63K
Sep 29, 2025 Curran Simpson N/A Sale 7.62K $10.03 $76.47K
Sep 10, 2025 Curran Simpson N/A Sale 7.73K $10.02 $77.49K
May 12, 2025 Kenneth T Mills N/A Sale 20.60K $7.91 $162.96K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 5.78M Mar 31, 2026 11.19% $0.00 0.45%
Redmile Group, LLC 4.37M Mar 31, 2026 8.45% $2.42 0.00%
JPMorgan Chase & Co 3.48M Mar 31, 2026 6.74% $0.00 -1.96%
Vanguard Group Inc 3.37M Dec 31, 2025 6.53% $0.00 1.08%
State Street Corp 2.73M Mar 31, 2026 5.28% $0.00 19.45%
Morgan Stanley - Brokerage Accounts 2.07M Mar 31, 2026 4.00% $0.00 2.55%
Vanguard Capital Management, LLC 2.01M Mar 31, 2026 3.88% $0.00 0.00%
The Goldman Sachs Group Inc 1.84M Mar 31, 2026 3.56% $0.00 3.03%
Integral Health Asset Management, LLC 1.50M Mar 31, 2026 2.90% $0.60 25.00%
Qube Research & Technologies 1.31M Mar 31, 2026 2.53% $0.01 196.03%
Geode Capital Management, LLC 1.14M Mar 31, 2026 2.20% $0.00 -0.67%
AQR Capital Management LLC 1.05M Mar 31, 2026 2.03% $0.00 -22.78%
Vanguard Portfolio Management, LLC 1.02M Mar 31, 2026 1.97% $0.00 0.00%
Dimensional Fund Advisors, Inc. 1.01M Mar 31, 2026 1.95% $0.00 11.79%
Assenagon Asset Management SA 980.61K Mar 31, 2026 1.90% $0.01 -15.49%
Nuveen, LLC 582.02K Mar 31, 2026 1.13% $0.00 -11.62%
Two Sigma Investments LLC 554.89K Mar 31, 2026 1.07% $0.00 327.03%
Pale Fire Capital SE 499.53K Dec 31, 2025 0.97% $0.48 95.43%
22NW, LP 492.76K Mar 31, 2026 0.95% $2.83 -46.65%
Northern Trust Corp 393.64K Mar 31, 2026 0.76% $0.00 5.34%

Shares Statistics

Shares Outstanding: 51.70M
Shares Float: 43.04M
% Insiders: 806.30%
% Institutions: 8,211.50%
Short % Float: 21.77%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 State Street® SPDR® S&P® Biotech ETF 1.52M 2.94% ▼ 0.62% May 31, 2026
2 Vanguard Total Stock Mkt Idx Inv 1.43M 2.76% ▲ 0.00% Apr 30, 2026
3 JPMorgan Small Cap Growth A 1.14M 2.21% ▼ 13.95% Apr 30, 2026
4 iShares Russell 2000 ETF 1.12M 2.17% ▲ 0.93% May 29, 2026
5 Nuveen Quant Small Cap Equity R6 630.21K 1.22% ▲ 34.17% Apr 30, 2026
6 Vanguard Institutional Extnd Mkt Idx Tr 535.36K 1.04% ▲ 0.64% Apr 30, 2026
7 Fidelity Small Cap Index 462.76K 0.90% ▲ 1.12% Mar 31, 2026
8 iShares Russell 2000 Value ETF 413.07K 0.80% ▲ 0.00% May 29, 2026
9 Vanguard Strategic Small-Cap Equity Inv 377.78K 0.73% ▲ 0.00% Mar 31, 2026
10 JPMorgan Small Cap Blend A 368.88K 0.71% ▼ 13.75% Apr 30, 2026

Valuation Metrics

Enterprise Value: $641.76M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $721.18M
EBITDA: $-241.17M
PEG Ratio: $0.26
Book Value: $0.41
Earnings/Share: $-5.60
Profit Margin: 0.00%
Operating Margin: -1,303.96%
ROA (TTM): -38.53%
ROE (TTM): -196.43%
Revenue (TTM): $87.82M
Revenue/Share (TTM): $1.69
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -92.80%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 2.38x 0.47x 0.77x -3.58x -0.36x
2024-12-31 2.69x 0.03x 0.44x -18.43x -0.04x
2023-12-31 2.57x 0.02x 0.46x -39.07x -0.03x
2022-12-31 3.19x 0.01x 0.38x -11.30x -0.02x
2021-12-31 3.98x 0.00x 0.31x 6.09x 0.01x
2020-12-31 6.52x 0.01x 0.47x -154.65x -0.03x
2019-12-31 10.25x 0.01x 0.10x -1.39x -0.03x
2018-12-31 15.24x 0.00x 0.06x N/A 0.00x
2017-12-31 11.64x 0.00x 0.08x N/A 0.00x
2016-12-31 9.66x 0.00x 0.06x N/A 0.00x
2015-12-31 27.23x 0.00x 0.02x -1,156.85x 0.00x
2014-12-31 0.33x -0.67x 2.63x -11.47x -1.05x
2013-12-31 0.47x -0.31x 1.85x -7.82x -0.14x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about RGNX.US!